About this briefing
Medtech innovation briefings summarise the published evidence and information available for individual medical technologies. The briefings provide information to aid local decision-making by clinicians, managers and procurement professionals.
Medtech innovation briefings aim to present information and critically review the strengths and weaknesses of the relevant evidence, but contain no recommendations and are not formal NICE guidance.
This briefing was developed for NICE by Cedar. The interim process and methods statement sets out the process NICE uses to select topics, and how the briefings are developed, quality-assured and approved for publication.
Mrs Kathleen Withers, Researcher, Cedar
Dr Helen Morgan, Information Specialist, Cedar
Dr James Evans, Researcher, Cedar
Dr Alistair Ray, Researcher, Cedar
Dr Judith White, Researcher, Cedar
Dr Grace Carolan-Rees, Director, Cedar
The following specialist commentators provided comments on a draft of this briefing:
Mr Hashim Hashim, Consultant Urological Surgeon, Southmead Hospital, Bristol
Professor Christopher Chapple, Consultant Urological Surgeon, Royal Hallamshire Hospital, Sheffield
Mr Angus MacCormick, Urology Speciality Nurse, Musgrove Park Hospital, Somerset
Professor Mark Emberton, Consultant Urological Surgeon, University College London Hospitals, London
Christopher Chapple has acted as: a consultant, speaker and trial participant for Allergan, Astellas, Medtronic and Recordati; a consultant and speaker for Lilly; and a speaker for Ranbaxy. He has also acted as a trial participant and speaker for ONO and Pfizer.
© National Institute for Health and Care Excellence, 2016. All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE.